Search

Department of Oncology

Research Labs

Radiation oncology

BOURHIS Lab

Research

Our focus

Our projects

KEY PUBLICATIONS

UNIL web teasers general.png

People

Meet all the Bourhis Lab Members.

Publications

Publications | Masters and Phd thesis

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

Publications

LOADING...

In Press | 2022 | 2021 | ...

In Press

Normal tissue sparing by FLASH as a function of single fraction dose: A quantitative analysis.

Böhlen T.T., Germond J.F., Bourhis J., Vozenin M.C., Ozsahin E.M., Bochud F., Bailat C., Moeckli R. International journal of radiation oncology, biology, physics. Peer-reviewed.

[DOI][Pmid][serval:BIB_03FA7A108554]

Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma.

Gaide O., Herrera F. G., Sozzi W.J., Gonçalves Jorge P., Kinj R., Bailat C., Duclos F., Bochud F., Germond J.F., Gondré M. et al. Radiotherapy and oncology. Peer-reviewed.

[DOI][Pmid][serval:BIB_3BC621CB1990]

Dose and volume limiting late toxicity of FLASH radiotherapy in cats with squamous cell carcinoma of the nasal planum and in mini-pigs.

Rohrer Bley C., Wolf F., Gonçalves Jorge P., Grilj V., Petridis I., Petit B., Böhlen T.T., Moeckli R., Limoli C., Bourhis J. et al. Clinical cancer research. Peer-reviewed.

[DOI][Pmid][serval:BIB_83A4D24300BD]

2022

preview resource BIB_86D6807F70CB.P001

Commissioning and validation of RayStation treatment planning system for CyberKnife M6.

Gondré M., Conrad M., Vallet V., Bourhis J., Bochud F., Moeckli R., 2022/07/20. Journal of applied clinical medical physics pp. e13732. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_86D6807F70CB]

Low-dose irradiation for reversing immunotherapy resistance: how to translate?

Ochoa-de-Olza M., Bourhis J., Coukos G., Herrera F.G., 2022/07. Journal for immunotherapy of cancer, 10 (7) pp. e004939. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DBBB9D3370A5]

Prise en charge des métastases cérébrales en 2022 [Management of brain metastases in 2022]

Schiappacasse L., Kinj R., De Micheli R., Mederos N., Tuleasca C., Cossu G., Dunet V., Levivier M., Bourhis J., Hottinger A.F., 2022/05/18. Revue medicale suisse, 18 (782) pp. 976-983. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_C341F49A8ECA]

Radiographic-anatomy, natural history and extension pathways of parotid and submandibular gland cancers.

Biau J., Nutting C., Langendijk J.A., Frédéric-Moreau T., Thariat J., Piram L., Bellini R., Saroul N., Pham Dang N., O'Sullivan B. et al., 2022/05. Radiotherapy and oncology, 170 pp. 48-54. Peer-reviewed.

[DOI][Pmid][serval:BIB_0FE2485183E1]

Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.

Bourhis J., Burtness B., Licitra L.F., Nutting C., Schoenfeld J.D., Omar M., Bouisset F., Nauwelaerts H., Urfer Y., Zanna C. et al., 2022/05. Future oncology, 18 (14) pp. 1669-1678. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0A17DBE552A8]

Radiotherapy plus immune checkpoint blockade in PD(L)-1-resistant metastatic NSCLC.

Ochoa-de-Olza M., Bourhis J., Coukos G., Herrera F.G., 2022/04. The Lancet. Oncology, 23 (4) pp. e157. Peer-reviewed.

[DOI][Pmid][serval:BIB_BC56553604E1]

preview resource BIB_D66CA0261E74.P001

Technical note: Validation of an ultrahigh dose rate pulsed electron beam monitoring system using a current transformer for FLASH preclinical studies.

Gonçalves Jorge P., Grilj V., Bourhis J., Vozenin M.C., Germond J.F., Bochud F., Bailat C., Moeckli R., 2022/03. Medical physics, 49 (3) pp. 1831-1838. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_D66CA0261E74]

Nurse-Led Consultation and Symptom Burden in Patients with Head and Neck Cancer: A Comparative Analysis of Routine Clinical Data.

Luta X., Colomer-Lahiguera S., Martins Cardoso R.J., Hof F., Savoie M., Schuler C., Wicht J., Fucina N., Debarge P., Ninane F. et al., 2022/02/26. Cancers, 14 (5) p. 1227. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_CAA0E94D9DB3]

Stereotactic Body Radiation Therapy in Patients with Oligometastatic Disease: Clinical State of the Art and Perspectives.

Kinj R., Muggeo E., Schiappacasse L., Bourhis J., Herrera F.G., 2022/02/23. Cancers, 14 (5) p. 1152. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1222E7500D6E]

preview resource BIB_5E1F27A9CF4B.P001

Validation of Monte Carlo dose calculation algorithm for CyberKnife multileaf collimator.

Gondré M., Marsolat F., Bourhis J., Bochud F., Moeckli R., 2022/02. Journal of applied clinical medical physics, 23 (2) pp. e13481. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_5E1F27A9CF4B]

Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients.

Blanchard P., Lee AWM, Carmel A., Wai Tong N., Ma J., Chan ATC, Hong R.L., Chen M.Y., Chen L., Li W.F. et al., 2022/01. Clinical and translational radiation oncology, 32 pp. 59-68. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_22AE66170C77]

preview resource BIB_D82928F3BB2B.P001

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.

Herrera F.G., Ronet C., Ochoa de Olza M., Barras D., Crespo I., Andreatta M., Corria-Osorio J., Spill A., Benedetti F., Genolet R. et al., 2022/01. Cancer discovery, 12 (1) pp. 108-133. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_D82928F3BB2B]

2021

A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients.

Khalladi N., Dejean C., Bosset M., Pointreau Y., Kinj R., Racadot S., Castelli J., Huguet F., Renard S., Guihard S. et al., 2021/12. Cancer radiotherapie, 25 (8) pp. 755-762. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_770454ACEC36]

Technical Note: Break-even dose level for hypofractionated treatment schedules.

Böhlen T.T., Germond J.F., Bourhis J., Vozenin M.C., Bailat C., Bochud F., Moeckli R., 2021/11. Medical physics, 48 (11) pp. 7534-7540. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A85E84A8CBCF]

Implementation and validation of a beam-current transformer on a medical pulsed electron beam LINAC for FLASH-RT beam monitoring.

Oesterle R., Gonçalves Jorge P., Grilj V., Bourhis J., Vozenin M.C., Germond J.F., Bochud F., Bailat C., Moeckli R., 2021/11. Journal of applied clinical medical physics, 22 (11) pp. 165-171. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_670F6488D9CD]

On the interplay effect for moving targets treated with the CyberKnife static tracking system.

Zeverino M., Jia Y., Charosky L., Bourhis J., Bochud F.O., Moeckli R., 2021/09/13. Physica medica, 90 pp. 30-39. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0E0223D7988A]

preview resource BIB_5205796889DB.P001

A new method to visualize and to spare the ureters during SBRT for oligo metastatic patients.

Muggeo-Bertin E., Moeckli R., Vallet V., Berthold D., Godin S., Bourhis J., Herrera F.G., 2021/09. Technical innovations & patient support in radiation oncology, 19 pp. 7-10. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_5205796889DB]

LOADING...

Phd thesis

Publications (3)

Study and modulation of the immune microenvironment in a pre-clinical lung cancer model to optimize radiation-therapy efficiency.

Boivin Gael, Vozenin Marie-Catherine, 2019., Université de Lausanne, Faculté de biologie et médecine, Bourhis Jean (dir.).

[serval:BIB_AB942FA3E259]

preview resource BIB_1C9878253833.P002

Normal Brain, Neural Stem Cells and Glioblastoma Responses to FLASH Irradiation

Montay-Gruel Pierre, 2018/08/24. 258, Université de Lausanne, Faculté de biologie et médecine, Vozenin Marie-Catherine (dir.).

[URN][serval:BIB_1C9878253833]

Epigenetic conséquences and therapeutic implications of ERG transcriptional activation in prostate cancer

Zoma Marita, 2018., Université de Lausanne, Faculté de biologie et médecine, Bourhis Jean (dir.).

[serval:BIB_71C6E011D8B5]

Funding, Resources & Links

Funding	Fondation ISREC Fond’Action Fond National Suisse
Affiliations	Lausanne University Hospital - CHUV
Links	Biography of Jean Bourhis (UNIL/2013, in French) Interview of Jean Bourhis (UNIL/Faculty of Biology & Medicine/2020, in French) 3 Questions to Jean Bourhis (Lausanne University Hospital/2020, in French) Contributions to Revue Médicale Suisse Media compilation @Planète Santé

Follow us:

CONTACT

Lausanne Oncology BOURHIS lab.png

Jean BOURHIS
Full Professor
Laboratory J. Bourhis

Department of oncology UNIL CHUV

Phone +41 21 314 46 66
Fax +41 21 314 46 01
Email

CONNECT WITH ME

Featured Publication ------------

Xxxxx

Xxxxx | Cell Reports Medicine 02/21

Ch. des Boveresses 155 - CH-1066 Epalinges
Switzerland
Tel. +41 21 692 59 92
Fax +41 21 692 59 95

Contact
Directories

Legal information
Sitemap
Edition

Ludwig Cancer Research

Université de Lausanne

Centre Hospitalier Universitaire Vaudois (CHUV)